Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of alendronate on function and pain in knee osteoarthritis
IRCT20180811040759N5Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alendronate in osteoarthritis (OA), sponsored by Rafsanjan University of Medical Sciences. Primary endpoints: Pain severity in knee osteoarthritis and Functional status in knee osteoarthritis. Started Oct 2023; status: completed.
02
Drugs
alendronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20180811040759N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180811040759N5.